Title
Category
Credits
Event date
Cost
MMCAP - The Race to End Drug Shortages
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 BDEA
03/23/2026
$0.00
This presentation will provide a powerful and practical perspective on drug shortages, beginning with the real-world patient impact and the life-or-death consequences when essential medicines areunavailable. Drawing from her lived experience as a parent and her leadership in building national supply chain solutions, she will demystify the complex pharmaceutical supply chain, explain its
MMCAP - Antipsychotic Update
  • 1.50 ABN
  • 1.25 ABSWE
  • 1.25 ACPE Pharmacy
  • 1.25 BDEA
03/24/2026
$0.00
The use of antipsychotic agents in psychiatry is ever-growing. New mechanisms are being developed and approved for managing psychosis and other disorders. This presentation will address common challenges with understanding new ways of managing psychosis, update the participant on strategies for appropriately dosing, switching, and managing the cost of LAI Antipsychotics, and review the current state of using antipsychotics for achieving success in managing major depression. Additionally, there will be a brief review of what is coming in the pipeline of antipsychotic drug development.
Gas Station Drugs: Emerging Substances, Hidden Risks, and Community Impact
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 BDEA
04/08/2026
$0.00
The sale of unregulated and often mislabeled substances—commonly referred to as “gas station drugs”—has expanded rapidly in convenience stores and vape shops. Marketed as legal alternatives or wellness products, these substances often contain psychoactive ingredients that pose significant risks to physical and mental health. This webinar will examine the evolving landscape of gas station drugs, including kratom, delta‑8 and delta- 9 products, and other emerging substances.